Joseph Thimons
Optometrist · Fairfield, CTNPI 1851371454
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $206,426 of the $340,171 with a category attached, or 60.7%. 33 manufacturers reported payments, led by Bausch & Lomb Americas Inc. at 27.0% of the total. Among optometrist clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 615 payments — averaging $553.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bausch & Lomb Americas Inc.$92K
- Sun Pharmaceutical Industries Inc.$63K
- Reichert, Inc.$50K
- Bausch & Lomb, A Division Of Bausch Health US, LLC$33K
- AbbVie$24K
- LKC Technologies, Inc.$18K
- plus $61K from 27 others
Across 1 payment — averaging $3300.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bausch Health US, LLC$3K
What the payments were for
- Consulting fees$96,70028%
- Speaking & faculty fees$206,42661%
- Travel & lodging$16,3445%
- Food & beverage$20,7026%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bausch & Lomb Americas Inc. | 136 | $91,922 |
| Sun Pharmaceutical Industries Inc. | 148 | $62,834 |
| Reichert, Inc. | 27 | $50,050 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 37 | $32,901 |
| AbbVie(2 entities) | 47 | $23,830 |
| LKC Technologies, Inc. | 6 | $17,550 |
| Novartis | 34 | $14,949 |
| Shire North American Group Inc | 21 | $11,431 |
| Oyster Point Pharma, Inc. | 16 | $7,436 |
| Sight Sciences, Inc. | 17 | $6,093 |
| Glaukos Corporation | 15 | $5,921 |
| Aerie Pharmaceuticals, Inc. | 18 | $4,159 |
| Kala Pharmaceuticals, Inc. | 5 | $2,557 |
| Alcon | 20 | $1,958 |
| Thea Pharma Inc. | 6 | $1,506 |
| Derma Sciences, Inc. | 2 | $1,350 |
| Carl Zeiss Meditec, Inc. | 8 | $895 |
| Tarsus Pharmaceuticals, Inc. | 8 | $601 |
| Eyevance Pharmaceuticals LLC | 3 | $534 |
| Biotissue Holdings Inc. | 10 | $459 |
| Rxsight Inc | 6 | $383 |
| Dompe US, Inc. | 6 | $153 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $125 |
| Maculogix, Inc. | 3 | $116 |
| Coopervision Inc. | 1 | $112 |
| Quidel Corporation | 3 | $94 |
| Optovue, Inc. | 1 | $71 |
| Amgen | 3 | $59 |
| Ocular Therapeutix, Inc. | 3 | $46 |
| Tearlab Corp | 1 | $23 |
| ANI Pharmaceuticals, Inc. | 1 | $19 |
| Mallinckrodt Enterprises LLC | 1 | $17 |
| Harrow Eye, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XIIDRA$77,127
- MIEBO$65,978
- CEQUA$59,489
- VYZULTA$34,767
- LUMIGAN$20,106
- RETEVAL$17,250
- COMBIGAN$16,954
- LOTEMAX SM$11,519
- ALPHAGAN P$5,400
- Radius XR$4,225
- Rhopressa$3,773
- Rocklatan$3,773
- TYRVAYA$3,631
- Ryzumvi$3,400
- OMNI(R) SURGICAL SYSTEM (US)$3,308
- EYSUVIS$2,510
- TearCare$2,250
- XELPROS$1,800
- IYUZEH$1,352
- BIODRESTORE$1,350
How this compares
$340,171 in reported general payments places this provider in the 95th percentile of 574 optometrist providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxervateCenegermin-Bkbj | 21 | $625,698 |
| RestasisCyclosporine | 126 | $143,006 |
| VyzultaLatanoprostene Bunod | 250 | $124,556 |
| XiidraLifitegrast | 31 | $52,965 |
| CequaCyclosporine | 35 | $30,591 |
| SimbrinzaBrinzolamide/Brimonidine Tart | 143 | $29,691 |
| LumiganBimatoprost | 43 | $20,572 |
| Cyclosporine | 29 | $17,360 |
| CombiganBrimonidine Tartrate/Timolol | 49 | $13,516 |
| Alphagan PBrimonidine Tartrate | 34 | $11,547 |
| Travoprost | 74 | $10,500 |
| RocklatanNetarsudil Mesylat/Latanoprost | 17 | $10,472 |
| Latanoprost | 628 | $6,436 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 97 | $6,369 |
| Prednisolone Acetate | 151 | $5,182 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Dompe US, Inc.Oxervate | $153 | $625,69821 claims |
| AbbVieRestasis, Lumigan, Combigan, Alphagan P | $23,830 | $188,641252 claims |
| Bausch & Lomb Americas Inc.Vyzulta, Xiidra | $91,922 | $177,521281 claims |
| Sun Pharmaceutical Industries Inc.Cequa | $62,834 | $30,59135 claims |
| AlconSimbrinza | $1,958 | $29,691143 claims |
| Aerie Pharmaceuticals, Inc.Rocklatan | $4,159 | $10,47217 claims |
| Bausch & Lomb, A Division Of Bausch Health US, LLCLoteprednol Etabonate | $32,901 | $3,92937 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 574 optometrist providers in Connecticut.
Other optometrist in Fairfield
- Inna LazarOld Greenwich$147K
- Jennifer StewartNew Canaan$91K
- Maria PribisStamford$78K
- Michael CooperWest Hartford$44K
- Joseph PavanoNew Britain$22K
- Susan JanikWest Hartford$20K
- Donald HigginsPlainville$18K
- Richard NowakEast Windsor$15K
- Barbara DuneHartford$14K
- Erin McClearyPlainville$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.